Shorb, M
Lonapegsomatropin: A Recent Pediatric Approval The FDA approved lonapegsomatropin (TransCon hGH, Ascendis Pharma) in 2021 for pediatric GH deficiency, providing once-weekly dosing [14]
Consult a healthcare provider if you are taking any other medication or have been diagnosed with chronic condition
If you're tracking progress during weight loss, rely on measurements, progress photos, how your clothes fit, and how you look in the mirror
Mitochondria are responsible for producing adenosine triphosphate (ATP), the energy currency of our cells
5 Note: If a Part D plan is an enhanced alternative coverage plan, drugs that would otherwise have to be excluded, including medication to treat obesity, may be covered by the plan as supplemental drugs